Meeting: Cancer R&D
Presenter Lauren V. Wood, M.D.
Abstract: Versamune® (R-D0TAP): A Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens
Session: Immunotherapy in Cancer
Date: Monday, October 26, 2020
Time: 11:00 a.m. ET

Receive Email Alerts

Join our mailing list to receive the latest news and updates from our team.

Sign up


This website use cookies to facilitate the use of the website, improve its performance and security, personalize the proposed content.